Biodesix Inc
BDSX- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001439725
In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Biodesix Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 52 | 1 | 59 | +8 |
| Shares | 62.4M | 45.1K | 58.8M | −3.52M (−5.7%) |
| Value | $111.2M | $80.3K | $89.9M | −$21.2M (−19.1%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Biodesix Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Samjo Management, LLC | 2,477,400 | $3.79M | 1.43% |
| Shay Capital LLC | 281,561 | $430.8K | 0.11% |
| 683 Capital Management, LLC | 257,765 | $394.4K | 0.04% |
| Stephens Inc | 197,917 | $302.8K | 0.00% |
| Goldman Sachs Group Inc | 118,035 | $180.6K | 0.00% |
| Omers Administration Corp | 100,943 | $154.4K | 0.00% |
| Jane Street Group, LLC | 77,840 | $119.1K | 0.00% |
| MYDA Advisors LLC | 50,000 | $76.5K | 0.02% |
| Boothbay Fund Management, LLC | 34,112 | $52.2K | 0.00% |
| Balyasny Asset Management LLC | 19,172 | $29.3K | 0.00% |
| Alpine Global Management, LLC | 15,974 | $24.4K | 0.01% |
| Schonfeld Strategic Advisors LLC | 15,728 | $24.1K | 0.00% |
| Marshall Wace, LLP | 15,058 | $23.0K | 0.00% |
| One68 Global Capital, LLC | 13,829 | $21.2K | 0.01% |
| Squarepoint Ops LLC | 13,510 | $20.7K | 0.00% |
| ACT Advisors, LLC. | 11,168 | $17.1K | 0.01% |
| BNP Paribas Arbitrage, SA | 1 | $2 | 0.00% |
| Simplex Trading, LLC | 71 | $0 | 0.00% |
Sold out (10)
Institutions that held Biodesix Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Sio Capital Management, LLC | 4,338,514 | $7.72M |
| Soleus Capital Management, L.P. | 4,038,065 | $7.19M |
| Essex Investment Management Co LLC | 971,197 | $1.73M |
| Legato Capital Management LLC | 334,310 | $595.1K |
| Heights Capital Management, Inc | 318,767 | $567.4K |
| Landscape Capital Management, L.L.C. | 146,941 | $261.6K |
| GTS Securities LLC | 80,330 | $143.0K |
| Cetera Investment Advisers | 78,000 | $138.8K |
| Oracle Investment Management Inc | 28,916 | $51.5K |
| Tower Research Capital LLC (TRC) | 2,952 | $5.25K |
Not filed for Q4 2024 yet (1)
Institutions that held Biodesix Inc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| AJOVista, LLC | 45,124 | $80.3K |